Dan Jeffries

Company: Negev Labs

Job title: Principal

Seminars:

Operator-Led Innovation: A Venture Studio Approach to Accelerating Neuropsychiatric Drug Development 11:45 am

Negev Labs Managing Partner Shlomi Raz will introduce the firm’s operator-led venture studio model, designed to identify and advance neuropsychiatric drug candidates through a capital-efficient, milestone-driven approach.  Shlomi will highlight Ariadne Bio, Negev Labs’ first portfolio company, which is developing a non-hallucinogenic 5-HT2A/2C agonist for apathy in Parkinson’s disease—an area of high unmet need—leveraging supportive…Read more

day: Day Two Track B - AM